{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-138316","form_type":"8-K","ticker":"ALLO","cik":"0001737287","company_name":"Allogene Therapeutics, Inc.","filed_at":"2024-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.818541+00:00","generated_at":"2026-06-02T01:00:45.028576+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Allogene Therapeutics raises $110M in registered equity offering at $2.90 per share with insider participation","bullets":["Offering of 37,931,035 shares at $2.90 per share for gross proceeds of ~$110M; expected to close May 16, 2024.","Insiders Arie Belldegrun, David Chang, and Geoffrey Parker each purchasing 344,828 shares in the offering.","Goldman Sachs & Co. LLC acted as sole underwriter; offering made under effective shelf registration statement.","Net proceeds after underwriting discounts and expenses will be used for general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-138316","json":"https://secwatch.observer/filing/0001193125-24-138316.json","markdown":"https://secwatch.observer/filing/0001193125-24-138316.md","text":"https://secwatch.observer/filing/0001193125-24-138316.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737287/000119312524138316/0001193125-24-138316-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737287/000119312524138316/d846176d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T01:00:45.028576+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}